Anti-Freaze-F

17/02/2023

to all of our trial sites - the trial is now closed to recruitment

02/02/2023

are you a GP or ? do you see patients with ? learn about Anti-Freaze-F comparing adalimumab versus placebo https://aff.octru.ox.ac.uk/welcome-antifreaze-f-trial University of Oxford sites across England

30/01/2023

Our colleagues at
East Sussex Healthcare NHS Trust

University Hospitals Birmingham NHS Foundation Trust
are participants to an innovative trial exploring how best to treat people with early stage frozen shoulder - learn more http://bit.ly/3XDnVqy

29/11/2022

🏴󠁧󠁢󠁥󠁮󠁧󠁿 did you know we have 4 sites open across ? Visit the website for details https://aff.octru.ox.ac.uk/sites-4

Sites open to recruitment Sites Principal Investigator Site Contact Email Telephone Conquest Hospital, East Sussex Healthcare NHS Trust Vincent Gallagher Toni De Freitas esht.clinicalresearch@nhs.net Sandwell & West Birmingham NHS Trust Neil Smith Rebecca Grenfell rebecca.grenfell1@nhs.net United Li...

25/10/2022

congratulations to Sandwell and West Birmingham NHS Trust for recruiting their first AFF participant

10/10/2022

The etiology of adhesive capsulitis involves inflammation, thickening and fibrosis of the shoulder capsule. The underlying genetic factors are poorly understood. The purpose of this study was to identify genetic variants associated with adhesive capsulitis utilizing the UK Biobank (UKB) cohort and c...

10/10/2022

to United Lincolnshire Hospitals NHS Trust - ULHT for recruiting their first Anti-Freaze-F participant

20/09/2022

to the team at East Sussex Healthcare NHS Trust for being the 4th Anti-Freaze-F site to open to

27/07/2022

congratulations to University Hospitals Birmingham NHS Foundation Trust for recruiting the first participant to AFF! novel

07/06/2022

Anti-Freaze-F will be open to recruitment at seven sites across England. Visit the trial page regularly to find a site near you if you'd like to find out more:

istock Shoulder Assessment Welcome to the ANTIFREAZE-F trial website Recruitment Progress quick summary block Information for Participants The Anti-Freaze-F trial is looking at the feasibility of conducting a large randomised controlled trial to assess whether an intra-articular injection of anti-T...

07/06/2022

Why does Anti-Freaze-F use the drug adalimumab?
Adalimumab is used widely to treat conditions such as rheumatoid arthritis, Crohn's disease and psoriasis. It helps to reduce swelling in the body. Frozen Shoulder is caused by inflammation of the tissue around the shoulder joint therefore its use for treating this condition is being explored. For more information about adalimumab visit https://www.nhs.uk/medicines/adalimumab/about-adalimumab/